Skip to content
Home/Companies/Biotech/BioHive

BioHive

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns BioHive?

BioHive is a French Biotech company, currently owned by 50 Partners since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
50 Partners
Investor
50 Partners
50 Partners Capital Health · 2022 · VC

Key facts

HQFrance
SectorBiotech

More from 50 Partners Capital Health

Other portfolio companies in the same fund.

Ekoria
Active
FintechFrance
Ed.ai
Active
EdTechFrance· 2026
Finoptis
Active
FintechFrance· 2026
Linc
Active
HR TechFrance· 2026
Reed Material
Active
France· 2026
Clear Surgery
Clear Surgery
Active
HealthcareFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns BioHive?

BioHive is currently owned by 50 Partners, through 50 Partners Capital Health, since 2025.

When did 50 Partners acquire BioHive?

50 Partners acquired BioHive in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue